• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multitarget Stool DNA Testing (Cologuard) for Colorectal Cancer Screening.

作者信息

Clebak Karl T, Nickolich Sarah, Mendez-Miller Megan

机构信息

Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

出版信息

Am Fam Physician. 2022 Feb 1;105(2):198-200.

PMID:35166507
Abstract
摘要

相似文献

1
Multitarget Stool DNA Testing (Cologuard) for Colorectal Cancer Screening.用于结直肠癌筛查的多靶点粪便DNA检测（Cologuard）
Am Fam Physician. 2022 Feb 1;105(2):198-200.
2
Multitarget stool DNA testing for colorectal-cancer screening.多靶点粪便 DNA 检测用于结直肠癌筛查。
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
3
Lowering Fecal Immunochemical Test Positivity Threshold vs Multitarget Stool RNA Testing for Colorectal Cancer Screening.降低粪便免疫化学检测阳性阈值与多靶点粪便RNA检测用于结直肠癌筛查的比较
JAMA. 2024 Jul 16;332(3):251-252. doi: 10.1001/jama.2024.9289.
4
In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.在年龄≥45 岁的人群中，mt-sRNA 检测对结直肠癌的敏感性为 94%，对高级腺瘤的敏感性为 46%。
Ann Intern Med. 2024 Feb;177(2):JC23. doi: 10.7326/J23-0114. Epub 2024 Feb 6.
5
A stool DNA test (Cologuard) for colorectal cancer screening.用于结直肠癌筛查的粪便DNA检测（Cologuard）。
Med Lett Drugs Ther. 2014 Oct 13;56(1453):100-1.
6
Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.结直肠癌的早期检测：一项用于验证联合DNA粪便检测的多中心临床前病例队列研究
Clin Lab. 2018 Oct 1;64(10):1719-1730. doi: 10.7754/Clin.Lab.2018.180521.
7
A novel multitarget stool DNA test for colorectal cancer screening.一种用于结直肠癌筛查的新型多靶点粪便DNA检测方法。
Postgrad Med. 2016;128(2):268-72. doi: 10.1080/00325481.2016.1135035. Epub 2016 Jan 12.
8
Multitarget stool DNA testing for colorectal-cancer screening.用于结直肠癌筛查的多靶点粪便DNA检测
N Engl J Med. 2014 Jul 10;371(2):187. doi: 10.1056/NEJMc1405215.
9
Multitarget stool DNA testing for colorectal-cancer screening.用于结直肠癌筛查的多靶点粪便DNA检测
N Engl J Med. 2014 Jul 10;371(2):186. doi: 10.1056/NEJMc1405215.
10
Multitarget stool DNA testing for colorectal-cancer screening.用于结直肠癌筛查的多靶点粪便DNA检测
N Engl J Med. 2014 Jul 10;371(2):185-6. doi: 10.1056/NEJMc1405215.

引用本文的文献

1
Microfluidic Liquid Biopsy Minimally Invasive Cancer Diagnosis by Nano-Plasmonic Label-Free Detection of Extracellular Vesicles: Review.通过纳米等离子体无标记检测细胞外囊泡的微流控液体活检微创癌症诊断：综述
Int J Mol Sci. 2025 Jul 1;26(13):6352. doi: 10.3390/ijms26136352.
2
Analysis of the effect of fecal SDC2, ADHFE1 and PPP2R5C gene methylation test for screening colorectal cancer in the Otog Front Banner.鄂托克前旗粪便SDC2、ADHFE1和PPP2R5C基因甲基化检测用于筛查结直肠癌的效果分析
BMC Gastroenterol. 2025 Apr 30;25(1):324. doi: 10.1186/s12876-025-03737-x.
3
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.
粪便和血液生物标志物在结直肠癌管理中的应用：筛查和疾病监测的最新进展。
Mol Cancer. 2024 Nov 19;23(1):259. doi: 10.1186/s12943-024-02174-w.
4
Multi-faceted strategies to advance health equity in colorectal cancer screening in primary care setting: quality improvement project.多层面策略在初级保健环境中推进结直肠癌筛查中的健康公平性：质量改进项目。
BMC Health Serv Res. 2024 Nov 18;24(1):1422. doi: 10.1186/s12913-024-11928-7.
5
Advances in blood DNA methylation-based assay for colorectal cancer early detection: a systematic updated review.基于血液DNA甲基化检测的结直肠癌早期诊断研究进展：系统更新综述
Gastroenterol Hepatol Bed Bench. 2024;17(3):225-240. doi: 10.22037/ghfbb.v17i3.2978.
6
Screening for colorectal cancer: Study on the shedding cells of feces.结直肠癌筛查：粪便脱落细胞研究
Cytojournal. 2024 Apr 25;21:16. doi: 10.25259/Cytojournal_107_2023. eCollection 2024.
7
Early-Onset Gastrointestinal Malignancies: An Investigation into a Rising Concern.早发性胃肠道恶性肿瘤：对一个日益受到关注的问题的调查
Cancers (Basel). 2024 Apr 18;16(8):1553. doi: 10.3390/cancers16081553.
8
The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs.精准表观遗传学方法在稳定型冠心病的诊断和治疗中的应用降低了医疗保健成本。
Adv Ther. 2024 Jun;41(6):2367-2380. doi: 10.1007/s12325-024-02860-7. Epub 2024 Apr 25.
9
Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters.使用循环肿瘤细胞（CTC）数量与其他临床参数的联合分析在增强癌症诊断、预后评估和监测方面的最新进展
Cancers (Basel). 2023 Nov 11;15(22):5372. doi: 10.3390/cancers15225372.
10
The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes.二甲双胍联合利拉鲁肽对中国 2 型糖尿病患者肠道菌群的影响。
Int Microbiol. 2024 Feb;27(1):265-276. doi: 10.1007/s10123-023-00380-y. Epub 2023 Jun 14.